
TELA Bio Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
Dec 22, 2025 · View real-time stock prices and stock quotes for a full financial overview.
TELA Bio (TELA) Stock Price & Overview
4 days ago · A detailed overview of TELA Bio, Inc. (TELA) stock, including real-time price, chart, key statistics, news, and more.
TELA Bio, Inc. (TELA) - Yahoo Finance
Find the latest TELA Bio, Inc. (TELA) stock quote, history, news and other vital information to help you with your stock trading and investing.
TELA Bio (TELA) Stock Price, News & Analysis - MarketBeat
2 days ago · TELA Bio, Inc. (NASDAQ: TELA) is a commercial‐stage medical technology company headquartered in Malvern, Pennsylvania. The company is focused on developing, manufacturing and …
TELA Bio Inc (TELA) Stock Price & News - Google Finance
Get the latest TELA Bio Inc (TELA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Investors | TELA Bio
TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet …
TELA: TELA Bio Inc - Stock Price, Quote and News - CNBC
Get TELA Bio Inc (TELA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Tela Bio (TELA) Sues Becton, Dickinson Over Hernia Mesh Market P
Dec 22, 2025 · TELA, Financial) has filed a lawsuit against Becton, Dickinson, alleging anti-competitive practices in the hernia mesh market. Tela Bio is a commercial-stage medical technology company …
Tela Bio sues BD over hernia mesh monopoly claims
Dec 23, 2025 · BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products …
TELA Bio to Announce Second Quarter 2025 Financial Results
Jul 21, 2025 · About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by...